Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis
Go back to Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis| (NASDAQ: ACON) | Delayed: 2.34 +0.03 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.31 | 52 Week High | $ | |||
| Open | $2.32 | 52 Week Low | $ | |||
| Day High | $2.37 | P/E | N/A | |||
| Day Low | $2.32 | EPS | $ | |||
| Volume | 7,298 | |||||
| (NASDAQ: ACONW) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 12 | |||||



